Aerosol inhalation therapy for the larynx is one of the most popular treatments for laryngeal diseases. However, both the guideline how to combine drugs and the adverse effects of this treatment remain unknown.
We investigated the adverse effects of this treat ment for the larynx from the two viewpoints as follows:
1) The effects on ciliary activity (CA) of osmotic pressure, pH, and stimulating agents to paranasal mucosal CA such as aspirin, predonisolone and erythromycin were investigated by a photo-electric method, using human tracheal mucosa. Furthermore, these effects were compared with those of human ethmoid mucosa.
CA of human ethmoidal mucosa was reduced in the solutions of 57, 570 and 875 mOsm/kg adjusted by H
2O or N
aCl. However, CA of tracheal mucosa wOas not reduced in 570mOsm/kg-solution adjusted by N
aCl. While CA of the ethmoidal mucosa in solutions between pH 4.5 and 6.5 was reduced, but CA of the trachea did not reduced.
tracheal mucosa were enhanced in the solutions between pH 8.5 and 10.5, or with predonisolone and erythromycin. Furthermore, aspirin enhanced CA of the tracheal mucosa more strongly than the ethmoidal mucosa. These results suggest that the same drugs used in nasal inhalation therapy could be used for the larynx almost in the same manner.
2) The clinical features of aerosol inhalation therapy for the larynx and its side effects were investigated using the mail questionnaire. Of 376 practitioners, 254 (67.6%) answered the questionnaire. Although various drugs were used in various concentrations in the inhalation, a few cases of side effects had no relationships among the kinds of inhalation drugs, the concentrations of drugs and the aerosol equipments. These questionnaire revealed that the clinical side effects of inhalation therapy for the larynx rarely occur unexpectedly. Therefore, we must observe the patients carefully during their inhalation therapy and give attention to sudden accidents.
View full abstract